$115.07
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+67.25%
1Y
+61.73%
YTD
+81.67%
Open$115.07
Previous Close$115.07
Day High$115.07
Day Low$115.07
52W High$115.13
52W Low$60.36
Volume—
Avg Volume2.16M
Market Cap6.73B
P/E Ratio—
EPS$-4.06
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$67.56
Above
SMA 200
$71.93
Above
RSI (14)
44.8
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Hold
14 analysts
Price Target
-15.7% upside
Current
$115.07
$115.07
Target
$96.95
$96.95
$73.10
$96.95 avg
$131.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 23.15M | 2.26B | 2.06B |
| Net Income | -237,773,068 | 113.46M | 99.51M |
| Profit Margin | -1,027.3% | 5.0% | 4.8% |
| EBITDA | -255,919,354 | 251.62M | 213.71M |
| Free Cash Flow | — | 62.68M | 52.56M |
| Rev Growth | — | +18.8% | +20.4% |
| Debt/Equity | — | 0.80 | 0.97 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |